Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000612924 | SCV000732546 | likely benign | not specified | 2017-06-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000620887 | SCV000740197 | likely benign | Cardiovascular phenotype | 2017-08-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001437113 | SCV001639960 | likely benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2024-04-09 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451462 | SCV004182069 | likely benign | Dilated cardiomyopathy 1D | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451463 | SCV004182081 | likely benign | Cardiomyopathy, familial restrictive, 3 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451461 | SCV004182092 | likely benign | Hypertrophic cardiomyopathy 2 | 2023-11-04 | criteria provided, single submitter | clinical testing |